Plain-English translation of NCT04432220 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
After a procedure called catheter ablation successfully treats irregular heartbeat, doctors aren't sure how long patients need to take blood thinner medications. This study compares two groups: one taking apixaban (a blood thinner) for two years, and another receiving standard care without the medication. The goal is to understand which approach is safer and more effective for people whose heart rhythm has stayed normal for at least one year after ablation.
People with irregular heartbeat are at higher risk of stroke, which is why blood thinners are commonly prescribed. However, it's unclear whether this medication is still necessary after successful ablation treatment, especially if the heart rhythm has remained normal. This trial will help doctors decide how long patients truly need this medication.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either take the blood thinner medication twice daily or receive standard care without it for two years. You'll visit the hospital regularly for checkups and heart monitoring to see how you're doing. If your irregular heartbeat returns at any point, you'll begin taking blood thinners as your doctor recommends and won't continue in the study comparison.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
South Korea